Skip to content
value.today

Tokalas, Inc.

🇺🇸 Del Mar, California, USABiotechnologyFounded 2013
Total raised
$45 M
4 rounds on record
Latest round
$17 M
Nov 2018
First round on record
Feb 2014
Today
Private
No later event on record

Funding rounds

4 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Tokalas, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2018$17 MNo. 4$10 to $50 million

Tokalas, Inc.: Raise no. 4, Nov 2018

Investors in this round

1 investor had bought by the notice of Nov 21, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $24 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James B. Breitmeyer, M.D., Ph.D. · Executive Officer, Director · President and Chief Executive Officer
  • Lauren G. Otsuki · Executive Officer · Chief Business Officer
  • Richard R. Vincent · Executive Officer · Chief Financial Officer
  • Cam R. Gallagher · Director
  • Charles G. Theuer, M.D. · Director
  • Cooper R. Collins · Director
  • David F. Hale · Director
  • Scott L. Glenn · Director
  • William R. LaRue · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James B. Breitmeyer, M.D., Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 21, 2018. Read the notice at the SEC.

equitySEC
Sep 2017$7 MNo. 3$2 to $10 million

Tokalas, Inc.: Raise no. 3, Sep 2017

Investors in this round

121 investors had bought by the notice of Sep 27, 2017: 121 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $11 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Series B-2 Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian B. Lannutti · Executive Officer · Chief Scientific Officer
  • James B. Breitmeyer, M.D., Ph.D. · Executive Officer, Director · President and Chief Executive Officer
  • Langdon G. Miller · Executive Officer · Chief Medical Officer
  • Lauren G. Otsuki · Executive Officer · Chief Business Officer
  • Richard B. Vincent · Executive Officer · Chief Financial Officer
  • Cam B. Gallagher · Director
  • Cam L. Garner · Director
  • Cooper B. Collins · Director
  • David B. Johnson · Director
  • David F. Hale · Director
  • Scott L. Glenn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James B. Breitmeyer, M.D., Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 27, 2017. Read the notice at the SEC.

equity, optionsSEC
May 2016$13 MIssued in a merger or acquisition$10 to $50 million

Tokalas, Inc.: Private sale, May 2016

Investors in this round

26 investors had bought by the notice of Jun 8, 2016: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dana F. McGowan · Executive Officer · Treasurer and Secretary
  • James B. Breitmeyer, M.D., Ph.D. · Director, Executive Officer · President and Chief Executive Officer
  • James G. Freddo · Executive Officer · Chief Medical Officer
  • Karen F. Lundgren · Executive Officer · Vice President and Chief Scientific Officer
  • Lauren G. Otsuki · Executive Officer · Chief Business Officer
  • Cam F. Garner · Director
  • David F. Hale · Director
  • David F. Johnson · Director
  • Scott F. Glenn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James B. Breitmeyer, M.D., Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 8, 2016. Read the notice at the SEC.

equitySEC
Jul 2015$18 MNo. 2$10 to $50 million

Tokalas, Inc.: Raise no. 2, Jul 2015

Investors in this round

111 investors had bought by the notice of Mar 23, 2017: 111 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $24 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian B. Lannutti · Executive Officer · Chief Scientific Officer
  • James B. Breitmeyer, M.D., Ph.D. · Executive Officer, Director · President and Chief Executive Officer
  • Langdon G. Miller · Executive Officer · Chief Medical Officer
  • Lauren G. Otsuki · Executive Officer · Chief Operating Officer
  • Cam B. Gallagher · Director
  • Cam L. Garner · Director
  • David B. Johnson · Director
  • David F. Hale · Director
  • Scott L. Glenn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James B. Breitmeyer, M.D., Ph.D., President and Chief Executive Officer. Source: SEC Form D and 4 amendments, newest notice filed Mar 23, 2017. Read the notice at the SEC.

equity, optionsSEC
Feb 2014$3 MNo. 1$2 to $10 million

Tokalas, Inc.: Raise no. 1, Feb 2014

Investors in this round

26 investors had bought by the notice of Mar 5, 2014: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Scott L. Glenn · Executive Officer, Director
  • Cam L. Garner · Director
  • David F. Hale · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Scott L. Glenn, Chief Executive Officer, President, Treasurer and Secretary. Source: SEC Form D, newest notice filed Mar 5, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Tokalas, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2018).

    SEC Form D · Nov 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2018

That is all the official record says: Tokalas, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Tokalas, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 121 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Tokalas, Inc.
NameRoleNamed in
James B. Breitmeyer, M.D., Ph.D.President and Chief Executive OfficerNov 2018
Lauren G. OtsukiChief Business OfficerNov 2018
Richard R. VincentChief Financial OfficerNov 2018
Brian B. LannuttiChief Scientific OfficerSep 2017
Langdon G. MillerChief Medical OfficerSep 2017
Richard B. VincentChief Financial OfficerSep 2017
Dana B. McGowanChief Financial Officer and TreasurerDec 2016
Dana F. McGowanTreasurer and SecretaryJun 2016
James G. FreddoChief Medical OfficerJun 2016
Karen F. LundgrenVice President and Chief Scientific OfficerJun 2016
James L. FreddoExecutive officerMar 2016
Karen L. LundgrenExecutive officerMar 2016
Scott L. GlennExecutive officerMar 2016
Karen G. LundgrenExecutive officerAug 2015
Cam R. GallagherDirectorNov 2018
Charles G. Theuer, M.D.DirectorNov 2018
Cooper R. CollinsDirectorNov 2018
David F. HaleDirectorNov 2018
James B. Breitmeyer, M.D., Ph.D.President and Chief Executive OfficerNov 2018
Scott L. GlennDirectorNov 2018
William R. LaRueDirectorNov 2018
Cam B. GallagherDirectorSep 2017
Cam L. GarnerDirectorSep 2017
Cooper B. CollinsDirectorSep 2017
David B. JohnsonDirectorSep 2017
Cam F. GarnerDirectorJun 2016
David F. JohnsonDirectorJun 2016
Scott F. GlennDirectorJun 2016